Cd4(+) T Cell Subsets during Virus Infection: Protective Capacity Depends on Effector Cytokine Secretion and on Migratory Capability

por Maloy, Kevin J., Burkhart, Christoph, Junt, Tobias M., Odermatt, Bernhard, Oxenius, Annette, Piali, Luca, Zinkernagel, Rolf M., Hengartner, Hans
Publicado 2000

Therapeutic Use of a Selective S1P(1) Receptor Modulator Ponesimod in Autoimmune Diabetes

por You, Sylvaine, Piali, Luca, Kuhn, Chantal, Steiner, Beat, Sauvaget, Virginia, Valette, Fabrice, Clozel, Martine, Bach, Jean-François, Chatenoud, Lucienne
Publicado 2013

Translational precision medicine: an industry perspective

por Hartl, Dominik, de Luca, Valeria, Kostikova, Anna, Laramie, Jason, Kennedy, Scott, Ferrero, Enrico, Siegel, Richard, Fink, Martin, Ahmed, Sohail, Millholland, John, Schuhmacher, Alexander, Hinder, Markus, Piali, Luca, Roth, Adrian
Publicado 2021

Cenerimod, a novel selective S1P(1) receptor modulator with unique signaling properties

por Piali, Luca, Birker‐Robaczewska, Magdalena, Lescop, Cyrille, Froidevaux, Sylvie, Schmitz, Nicole, Morrison, Keith, Kohl, Christopher, Rey, Markus, Studer, Rolf, Vezzali, Enrico, Hess, Patrick, Clozel, Martine, Steiner, Beat, Bolli, Martin H., Nayler, Oliver
Publicado 2017

A randomized, double‐blind phase 1b study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of the NLRP3 inhibitor selnoflast in patients with moderate to...

por Klughammer, Barbara, Piali, Luca, Nica, Alexandra, Nagel, Sandra, Bailey, Lorna, Jochum, Christoph, Ignatenko, Stanislav, Bläuer, Angela, Danilin, Sabrina, Gulati, Pratiksha, Hayward, Joanne, Scepanovic, Petar, Zhang, Jitao David, Bhosale, Satish, Chong, Chui Fung, Christ, Andreas
Publicado 2023